Efficacy and safety of up to 192 weeks of etanercept therapy in patients with ankylosing spondylitis.

Abstract

OBJECTIVE Evaluate long-term safety and efficacy of etanercept treatment in patients with ankylosing spondylitis (AS). METHODS Patients with AS who previously participated in a randomised controlled trial (RCT) of etanercept were eligible to enroll in a 168-week open-label extension (OLE). Safety end points included rates of adverse events (AE), serious… (More)

Topics

7 Figures and Tables

Slides referencing similar topics